Latest News

Title
Pancreatic Cancer
03 Jul 2013 European Medicines Agency Recommends Granting a Marketing Authorisation for Regorafenib Gastrointestinal cancers - Anticancer agents & Biologic therapy
02 Jul 2013 European Medicines Agency Recommends Granting a Marketing Authorisation for Dabrafenib Melanoma - Anticancer agents & Biologic therapy
02 Jul 2013 Pancreatic Cancer: Tackling the Tumour by Targeting its Surroundings Translational research - Gastrointestinal cancers
27 Jun 2013 Confronting the Complexity of EGFR/HER Targeted Therapies in Breast, Colorectal and Lung Cancers Personalised medicine
26 Jun 2013 A Comprehensive Genomic Mutation Profiling Analysis of Adenoid Cystic Carcinoma Pathology/Molecular biology - Translational research - Head and neck cancers
25 Jun 2013 Identifying the Drivers of Breast Cancer Breast cancer - Translational research
24 Jun 2013 A Novel Agent, Ibrutinib, Shows Potential as a Safe, Effective, Targeted Treatment Haematologic malignancies - Anticancer agents & Biologic therapy
19 Jun 2013 Just 11 Percent of Adults and 5 Percent of Children Participate in Medical Research Bioethics, legal and economic issues
18 Jun 2013 EMUC 2013 Press Release: From Guidelines to Personalised Medicine 5th EMUC Examines Personalised Therapies for Urological Cancers Genitourinary cancers
17 Jun 2013 BioMarker IGF Project Aims to Identify and Validate Biomarkers for the IGF-1 Signalling Pathway in Cancer Personalised medicine - Translational research
13 Jun 2013 First-line Treatment Strategies for Advanced-Stage Follicular Lymphoma: Which is The Best One? Haematologic malignancies
Melanoma
06 Jun 2013 European Medicines Agency recommends granting a marketing authorisation for lipegfilgrastim Palliative and supportive care - Anticancer agents & Biologic therapy